← All Spyre Therapeutics, INC filings

Spyre Therapeutics, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
SYRE
Spyre Therapeutics, INC
SCHEDULE: Fairmount Funds Trims Spyre Stake in $400M Block Trade
Fairmount Funds Management reduced its position in Spyre Therapeutics through a significant block trade following the conversion of preferred shares and a board resignation.
NASDAQ
SYRE
Spyre Therapeutics, INC
SCHEDULE: Fairmount Funds Enters Lock-Up for Spyre Therapeutics
Fairmount Funds Management LLC and its principals have entered into a 60-day lock-up agreement following Spyre Therapeutics' recent underwritten public offering.
NASDAQ
SYRE
Spyre Therapeutics, INC
SCHEDULE: Fairmount Funds Disclose Spyre Therapeutics Lock-Up
Fairmount Funds Management and related parties filed an amended Schedule 13D, reporting a 60-day lock-up agreement on Spyre Therapeutics shares following a public offering.